Live feed08:00:31·895dSECFilingvia QuantisnowAllogene Therapeutics Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Other Events, Costs Associated with Exit or Disposal ActivitiesByQuantisnow·Wall Street's wire, on your screen.ALLO· Allogene Therapeutics Inc.Health CareOriginal source
